BIOPROM opens in Gelendzhik Medical technology on show

Oct 5

Alena Evtyakova reports from the third BIOPROM forum's opening in Gelendzhik. Exhibitors describe biodegradable magnesium surgical implants, Rostec's individualized skin bioprinting robot still undergoing clinical evaluation, and a domestic dialysis machine with monitoring features and proposed production and deliveries. Sechenov University and Sirius representatives discuss specialist training and a development-to-validation cycle. A pharmaceutical executive argues Russia can manufacture complex medicines domestically. Denis Manturov discusses the approved bioeconomy strategy through 2036 and reports three-percent output growth over nine months; Mikhail Kovalchuk explains everyday microbial production and emphasizes biosecurity. The report gives the exhibition and business programme's scale and says the forum continues tomorrow. Testing, forecasts and independence claims retain attribution and qualifications.

The third BIOPROM forum opens in Gelendzhik on October 5. Vremya's on-site report presents implant, bioprinting, dialysis, pharmaceutical and training exhibits, the business programme and biosecurity discussion. Clinical evaluation, production forecasts and capability claims remain qualified and attributed. The next day is scheduled; completion or proposed deliveries are not established. The third BIOPROM forum opens at Gelendzhik Arena on October 5, 2026, with a main strategy session on an ecosystem for a high quality of life. Manturov reads Putin's welcome and addresses officials, scientists and businesses. Vremya's on-scene report describes medical and biotechnology exhibits, around one hundred participating companies, a 7,000-square-metre exhibition and around forty programme events, and says the forum continues the next day. Product capabilities, trials and delivery expectations remain attributed to the report and exhibitors.